ArticleFrontiers in psychiatry2026

Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia: a

Yoshiteru Takekita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.